BCL2 and neuroblastoma: As shown in Figure 5A, the expression of Bcl-2, one of the anti-apoptotic proteins, was dramatically decreased in METH-treated SH-SY5y neuroblastoma cells but was rescued in lupenone pre-treated cells.